Haleon to set up 1st manufacturing unit in India, South Asia, invest Rs 2k cr

NEW DELHI: Haleon, formerly GSK Consumer Healthcare, will invest about Rs 2,000 crore (£175 million) to establish its first manufacturing facility in India and South Asia, as the UK firm doubles down on high-growth markets. The move follows the company’s recent investment in China, highlighting the increasing role of emerging markets, which account for about 35% of its business but contribute more than half of its growth.

Raccontata dathehindubusinessline.comnewsbytesapp.commorningstar.comtimesofindia.indiatimes.comeconomictimes.indiatimes.com